The 7 analysts offering 1 year price forecasts for 430 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 8 analysts giving stock ratings to 430 in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
430 EPS for the last quarter is −0.25 EUR despite the estimation of −0.29 EUR. In the next quarter EPS is expected to reach −0.29 EUR. Track more of TERNS PHARMACEUTICALS INC financials and stay on top of what is up with the company.
According to analysts, 430 price target is 18.31 EUR with a max estimate of 32.40 EUR and a min estimate of 7.15 EUR. Check if this forecast comes true in a year, meanwhile watch TERNS PHARMACEUTICALS INC stock price chart and keep track of the current situation with 430 news and stock market news.
We've gathered opinions of 8 analysts rating 430 stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.